Pharmacodynamics of Vildagliptin in Patients With Type 2 Diabetes During OGTT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacodynamics of Vildagliptin in Patients With Type 2 Diabetes During OGTT

Published:2007-05 Issue:5 Volume:47 Page:633-641
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

He Yan-Ling,Wang Yibin,Bullock Julie M.,Deacon Carolyn F.,Holst Jens Juul,Dunning Beth E.,Ligueros-Saylan Monica,Foley James E.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Plasma insulin responses to oral and intravenous glucose administration;Elrick;J Clin Endocrinol Metab,1964

2. The incretin concept today;Creutzfeldt;Diabetologia,1979

3. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations;Nauck;J Clin Endocrinol Metab,1993

4. Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes;Ahren;Diabetes Care,2004

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-01

2. A systematic review on the clinical pharmacokinetics of vildagliptin in healthy and disease populations;Expert Opinion on Drug Metabolism & Toxicology;2023-11-26

3. Pharmacotherapy of type 2 diabetes: An update and future directions;Metabolism;2022-12

4. Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment;Molecules;2022-05-10

5. Glucose‐lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase‐4 inhibition;Journal of Diabetes Investigation;2021-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3